111 related articles for article (PubMed ID: 2438489)
1. Vascular angiotensin conversion in humans.
Webb DJ; Collier JG
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S40-4. PubMed ID: 2438489
[TBL] [Abstract][Full Text] [Related]
2. Influence of ramipril diacid on the peripheral vascular effects of angiotensin I.
Webb DJ; Collier JG
Am J Cardiol; 1987 Apr; 59(10):45D-49D. PubMed ID: 2953225
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin converting enzyme inhibitors on the vasoconstrictor action of angiotensin I on isolated rat kidney.
Schmidt M; Giesen-Crouse EM; Krieger JP; Welsch C; Imbs JL
J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S100-5. PubMed ID: 2438482
[TBL] [Abstract][Full Text] [Related]
4. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
[TBL] [Abstract][Full Text] [Related]
5. Functional importance of angiotensin-converting enzyme-dependent in situ angiotensin II generation in the human forearm.
Saris JJ; van Dijk MA; Kroon I; Schalekamp MA; Danser AH
Hypertension; 2000 Mar; 35(3):764-8. PubMed ID: 10720592
[TBL] [Abstract][Full Text] [Related]
6. The urinary bladder angiotensin system: response to infusions of angiotensin I and angiotensin-converting enzyme inhibitors.
Weaver-Osterholtz D; Reams G; Wu Z; Knaus J; Campbell F; Bauer JH
Am J Kidney Dis; 1996 Oct; 28(4):603-9. PubMed ID: 8840953
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
[TBL] [Abstract][Full Text] [Related]
8. [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
Meyer-Lehnert H; Jahnecke C; Kappes-Horn K; Kramer HJ
Klin Wochenschr; 1991; 69 Suppl 24():45-9. PubMed ID: 1650862
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin II and losartan in the forearm of patients with essential hypertension.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
J Hypertens; 1998 Sep; 16(9):1299-305. PubMed ID: 9746117
[TBL] [Abstract][Full Text] [Related]
10. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.
Levitt DG; Schoemaker RC
BMC Clin Pharmacol; 2006 Jan; 6():1. PubMed ID: 16398929
[TBL] [Abstract][Full Text] [Related]
11. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
[TBL] [Abstract][Full Text] [Related]
12. ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression.
Schmeisser A; Soehnlein O; Illmer T; Lorenz HM; Eskafi S; Roerick O; Gabler C; Strasser R; Daniel WG; Garlichs CD
Biochem Biophys Res Commun; 2004 Dec; 325(2):532-40. PubMed ID: 15530425
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evidence of peripheral conversion of angiotensin within the human leg: effects of local angiotensin-I administration and angiotensin-converting enzyme inhibition on regional blood flow and angiotensin-II balance across the leg.
Gasic S; Heinz G; Kleinbloesem C
Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):436-40. PubMed ID: 2147739
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Zhuo J; Casley D; Murone C; Mendelsohn FA
J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin I to angiotensin II conversion in the human forearm and leg. Effect of the angiotensin converting enzyme gene insertion/deletion polymorphism.
Danser AH; Deinum J; Osterop AP; Admiraal PJ; Schalekamp MA
J Hypertens; 1999 Dec; 17(12 Pt 2):1867-72. PubMed ID: 10703882
[TBL] [Abstract][Full Text] [Related]
16. Levels of brain angiotensin in the spontaneously hypertensive rat and treatment with ramiprilat.
Phillips MI; Kimura BK
J Hypertens Suppl; 1986 Dec; 4(6):S391-4. PubMed ID: 3475423
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of ramipril and ramiprilat in healthy cats.
Desmoulins PO; Burgaud S; Horspool LJ
J Vet Pharmacol Ther; 2008 Aug; 31(4):349-58. PubMed ID: 18638296
[TBL] [Abstract][Full Text] [Related]
18. [3H]ramiprilat binding to the angiotensin-converting enzyme in rat renal brush-border membranes: the effect of chloride.
Grima M; Mosser J; Welsch C; Barthelmebs M; Imbs JL
Eur J Pharmacol; 1991 Mar; 206(3):203-9. PubMed ID: 1649762
[TBL] [Abstract][Full Text] [Related]
19. Vascular angiotensin-converting enzyme expression regulates local angiotensin II.
Müller DN; Bohlender J; Hilgers KF; Dragun D; Costerousse O; Ménard J; Luft FC
Hypertension; 1997 Jan; 29(1 Pt 1):98-104. PubMed ID: 9039087
[TBL] [Abstract][Full Text] [Related]
20. Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
Campbell DJ; Kladis A; Duncan AM
Hypertension; 1993 Oct; 22(4):513-22. PubMed ID: 8406656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
